About FDA
Office of Generic Drugs: Chemistry and Bioequivalence Review Teams
Division of Chemistry I Teams
| Chemistry 1 | Major Therapeutic Class | Project Manager | Bioequivalence | Bioequivalence Project Manager |
|---|---|---|---|---|
| Team 1 | Antihypertensives ACE Inhibitors Angeotensin II Receptor Antagonists Vasodilators-Prostiglandins Radiopharmaceutics Radiopaques Non-Steriodal Anti-Inflammatories (NSAIDS) |
Dat Doan 240-270-8573 FAX 240-276-8504 |
Divison 1 Team 4 |
Nam (Esther) Chun/Diana Solana
|
| Team 2 | Oncology Agents Neoplastic Hormonal Agents Immunomodulators Inhalation Corticosteriods Respiratory Agents Antiasthmatic Agents Decongestant Agents Expectorants/antitussives |
Esther Chuh 240-276-8530 FAX 240-276-8504 |
Divison 1 Team 8 |
Nam (Esther) Chun 240-276-8782 |
| Team 3 | Dermatologics Otics Ophthalmics Antifungal Agents-topicals Anti-Infectives-Quinolones Retinoid Products |
Nitin Patel 240-276-8548 FAX 240-276-8582 |
Division 1 Team 6 |
Diana S0lana 240-276-8782 |
| Team 5 | Diuretics Sedatives-Hypnotics Antifungals-systemics Estrogens Anti-Infectives Antiprotozoals Obsessive/Compulsive Agents Corticosteriods Benign Prostate Disease Agents |
Benjamin Danso 240-276-8527 FAX 240-276-8504 |
Division 1 Team 6 |
Diana Solana 240-276-8782 |
Division of Chemistry II Teams
| Chemistry II | Major Therapeutic Class | Project Manager | Bioequivalence | Bioequivalence Project Manager |
|---|---|---|---|---|
| Team 7 | Anti-Ulcer Antimotility/Antispasmodics Anticholinergics Anorexics CNS Agents Bipolar Disorders Fibrinolytics/Thromboembolics GI Diagnostics Anti-Parkinson Agents |
Theresa Liu 240-276-8555 FAX 240-276-8582 |
Division 2 Team 7 |
Diane Nhu 240-276-8782 |
| Team 8 | Beta Blockers Calcium Channel Blockers Anti-Arrhythmics Drug Abuse Agents Vasodilators Glycosides |
Simon Eng 240-276-8529 FAX 240-276-8504 |
Division 2 Team 1 |
Keri Suh 240-276-8782 |
| Team 9 | Antivirals Non-narcotic Analgesics Narcotic Analgesics Narcotic Antagonists/Agonists Migraine Agents Antifungal Agents - systemic |
Laura Longstaff 240-276-8548 FAX 240-276-8582 |
Division 2 Team 5 |
Diane Nhu 240-276-8782 |
| Team 10 | Antidepressants Attention Deficit-Hyperactivity Disorder Agents Nicotine/Anti-nicotine Agents Coagulants/Anticoagulants |
Tom Hinchliffe 240-276-8536 FAX 240-276-8582 |
Division 2 Team 3 |
Keri Suh 240-276-8782
|
Division of Chemistry III Teams
| Chemistry III | Major Therapeutic Class | Project Manager | Bioequivalence | Bioequivalence Project Manager |
|---|---|---|---|---|
| Team 4 | Antipsychotics Vitamins Antihistamines-Cough Preps Muscle Relaxants Oral Contraceptive Agents Androgens/Anabolic Steroids Dental Products |
Leigh Ann Bradford 240-276-8453 FAX 240-276-8474 |
Division 1 Team 2 |
Steven Mazzella 240-276-8782 |
| Team 6 |
Antibiotics *Fermentation derived |
Roberta Szydlo 240-276-8476 FAX 240-276-8474 |
Division 2 Teams 3 and 7 |
Keri Suh 240-276-8782 |
| Team 11 | Alzheimers Agents Anticonvulsants Antituberculosis Agents Ophthalmic Antibiotics Hyper/Hypoglycemics Sexual Dysfunction Agents |
Lisa Kwok 240-276-8494 FAX 240-276-8474 |
Division 2 Teams 1 and 5 |
Keri Suh 240-276-8782
|
| Team 12 | Anti-Anxiety Agents Anti-Alcoholism Potassium Salts Cholesterol lowering Agents Surgical Agents Anesthesia Agents Anti-malarial Agents Large Volume Parenterals Nutrients/Amino Acids |
Jeanne Skanchy 240-276-8467 FAX 240-276-8474 |
Division 1 Teams 6 and 8 |
Nam (Esther) Chun or Diana Solana 240-276-8782 |